MOLN — MOLECULAR PARTNERS AG
As of Q2 2026, 3 SEC-registered investment managers reported holding MOLN (MOLECULAR PARTNERS AG) in their latest 13F filings, with a combined reported value of $67.78K across 17.82K shares. That is +4756.9% by share count (+17.46K shares) versus the previous quarter, while reported value moved +4552.0%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 2 opened new positions. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
MOLN is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Q2 2026 — 3 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Citadel Advisors history | 17.18K | $65.28K | 0.00% | New |
| Morgan Stanley history | 367 | $1.42K | 0.00% | Hold |
| UBS Group AG history | 279 | $1.08K | 0.00% | New |
Q1 2026 — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Morgan Stanley history | 367 | $1.46K | 0.00% | Hold |
Q4 2025 — 2 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Morgan Stanley history | 367 | $1.60K | 0.00% | Hold |
| UBS Group AG history | 349 | $1.52K | 0.00% | Reduce |
Q3 2025 — 3 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| UBS Group AG history | 5.34K | $19.81K | 0.00% | Reduce |
| Morgan Stanley history | 367 | $1.36K | 0.00% | Hold |
| Bank of America Corp history | 157 | $582 | 0.00% | Hold |
Q2 2025 — 3 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| UBS Group AG history | 10.20K | $38.96K | 0.00% | Add |
| Morgan Stanley history | 367 | $1.40K | 0.00% | Hold |
| Bank of America Corp history | 157 | $600 | 0.00% | Hold |
Q1 2025 — 3 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| UBS Group AG history | 6.35K | $24.64K | 0.00% | Reduce |
| Morgan Stanley history | 367 | $1.42K | 0.00% | Hold |
| Bank of America Corp history | 157 | $609 | 0.00% | New |
New Positions (Q2 2026)
- Citadel Advisors 17.18K sh · $65.28K
- UBS Group AG 279 sh · $1.08K
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 7 funds)
| Fund | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Citadel Advisors | 17.18K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Morgan Stanley | 367 | 367 | 367 | 367 | 367 | 367 | 367 | 500 | 367 | 367 | 367 | 367 | 367 | 367 | 367 | 367 | 367 | 367 | — | — |
| UBS Group AG | 279 | — | 349 | 5.34K | 10.20K | 6.35K | 6.87K | 5.25K | 3.46K | 326 | — | — | — | — | 2.96K | — | — | 611 | 3.41K | — |
| Bank of America Corp | — | — | — | 157 | 157 | 157 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| JPMorgan Chase & Co | — | — | — | — | — | — | — | — | — | — | 1 | — | — | — | — | — | — | — | — | — |
| Citigroup Inc | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 6.00K | 6.00K | — | — | — |
| Millennium Management | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 23.94K | 32.33K | 66.03K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details